MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/ciu209

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014

Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death.

Velásquez Gustavo E, Becerra Mercedes C, Gelmanova Irina Y, Pasechnikov Alexander D, Yedilbayev Askar, Shin Sonya S, Andreev Yevgeny G, Yanova Galina, Atwood Sidney S, Mitnick Carole D, Franke Molly F, Rich Michael L, Keshavjee Salmaan

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Evidence is sparse regarding the optimal construction of regimens to treat multidrug-resistant (MDR) tuberculosis disease due to strains of Mycobacterium tuberculosis resistant to at least both isoniazid and rifampin. Given the low potency of many second-line antituberculous drugs, we hypothesized that an aggressive regimen of at least 5 likely effective drugs during the intensive phase, including a fluoroquinolone and a parenteral agent, would be associated with a reduced risk of death or treatment failure.

METHODS

We conducted a retrospective cohort study of patients initiating MDR tuberculosis treatment between 2000 and 2004 in Tomsk, Russian Federation. We used a multivariate Cox proportional hazards model to assess whether monthly exposure to an aggressive regimen was associated with the risk of death or treatment failure.

RESULTS

Six hundred fourteen individuals with confirmed MDR tuberculosis were eligible for analysis. On multivariable analysis that adjusted for extensively drug-resistant (XDR) tuberculosis-MDR tuberculosis isolates resistant to fluoroquinolones and parenteral agents-we found that monthly exposure to an aggressive regimen was significantly associated with a lower risk of death or treatment failure (hazard ratio, 0.52 [95% confidence interval, .29-.94]; P = .030).

CONCLUSIONS

Receipt of an aggressive treatment regimen was a robust predictor of decreased risk of death or failure during MDR tuberculosis treatment. These findings further support the use of this regimen definition as the benchmark for the standard of care of MDR tuberculosis patients and should be used as the basis for evaluating novel therapies.

Для цитирования: Velásquez Gustavo E, Becerra Mercedes C, Gelmanova Irina Y, Pasechnikov Alexander D, Yedilbayev Askar, Shin Sonya S, Andreev Yevgeny G, Yanova Galina, Atwood Sidney S, Mitnick Carole D, Franke Molly F, Rich Michael L, Keshavjee Salmaan. Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014. DOI: 10.1093/cid/ciu209.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.